Ameridose recalls all drugs

Ameridose LLC agreed to recall all products Wednesday after federal investigators found flaws in the company's sterilization process, the Boston Globe reported.
Ameridose is a sister company to the Framingham pharmacy linked to drugs that are suspected to have aided in hundreds of fungal infections and 29 deaths in the country, the Globe said.
"Ameridose and FDA agree that the use of injectable products that are not sterile can represent a serious hazard to health," the company said in a statement, Reuters reported.
The halt of Ameridose's products could lead to a shortage of supply, Reuters said.
""This is a company that produces and ships a lot of sterile injectables. We are trying to mitigate the effects (of the Ameridose recall) on drug supplies," Jane Woodcock, FDA director of theCenter for Drug Evaluation and Research, said.